Finith Jernigan

Head Of Early Discovery at Psivant Therapeutics

Finith Jernigan, Ph.D. is an experienced professional who currently holds the position of Head of Molecular Design at Psivant Therapeutics. Prior to this, Finith served as a Principal at Roivant Sciences and held various positions at different companies including PTC Therapeutics, Inc. and Silicon Therapeutics. With a background in Chemistry, Finith has made significant contributions in the field of drug discovery through computational design and virtual screening efforts.

Links

Previous companies

PTC Therapeutics logo

Org chart